Mayne Pharma Group Ltd (MAYNF)
4.46
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Mayne Pharma Group Debt to Equity Ratio: 0.0668 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0668 |
| June 30, 2023 | 0.0619 |
| December 31, 2022 | 0.1018 |
| June 30, 2022 | 0.7178 |
| December 31, 2021 | 0.5193 |
| June 30, 2021 | 0.4385 |
| December 31, 2020 | 0.4566 |
| June 30, 2020 | 0.3752 |
| December 31, 2019 | 0.3564 |
| June 30, 2019 | 0.3665 |
| December 31, 2018 | 0.3059 |
| June 30, 2018 | 0.305 |
| December 31, 2017 | 0.3196 |
| June 30, 2017 | 0.2608 |
| December 31, 2016 | 0.2308 |
| Date | Value |
|---|---|
| June 30, 2016 | 0.2117 |
| December 31, 2015 | 0.1897 |
| June 30, 2015 | 0.1987 |
| December 31, 2014 | 0.3271 |
| June 30, 2014 | 0.3016 |
| December 31, 2013 | 0.4151 |
| June 30, 2013 | 0.3863 |
| December 31, 2012 | 0.3912 |
| June 30, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| June 30, 2011 | 0.0968 |
| December 31, 2010 | 0.8219 |
| June 30, 2010 | 0.3372 |
| December 31, 2009 | 0.5621 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0619
Minimum
Jun 2023
0.7178
Maximum
Jun 2022
0.3461
Average
0.3709
Median
Debt to Equity Ratio Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 0.00 |
| Mesoblast Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 785.30M |
| Total Liabilities (Quarterly) | 412.10M |
| Shareholders Equity (Quarterly) | 373.20M |
| Current Ratio | 1.608 |
| Net Debt Paydown Yield | 24.51% |